M. Ishikawa et al., EFFECTS OF ORAL-ADMINISTRATION OF ERYTHRITOL ON PATIENTS WITH DIABETES, Regulatory toxicology and pharmacology, 24(2), 1996, pp. 303-308
Erythritol (20 g in solution) was administered orally in a single-dose
to 5 patients with diabetes. Serum erythritol levels reached a peak 1
hr after administration and then declined rapidly. Total urinary excr
etion was 82.0 +/- 3.7% within 24 hr and 88.5 +/- 3.3% within 72 hr. S
erum glucose and insulin levels remained unchanged until a meal was ta
ken (3 hr after erythritol administration) and then increased. Free fa
tty acids and 3-hydroxybutyric acid levels increased after erythritol
administration but dropped after ingestion of food. In a separate clin
ical trial, erythritol (20 g) was administered orally daily for 14 day
s to 11 patients with diabetes. Mean serum glucose and hemoglobin Ale
levels decreased over the time period. Indices of renal function-blood
urea nitrogen, creatinine, and beta(2)-microglobulin-did not change s
ignificantly. The single dose study suggests that erythritol exerts no
significant effects on the metabolism of diabetic patients. Two-week
daily administration of erythritol had no adverse effect on blood gluc
ose control. (C) 1996 Academic Press, Inc.